Physiomics announces retail offer to raise £70,000

Published 13/02/2025, 08:04
Physiomics announces retail offer to raise £70,000

LONDON - Physiomics plc (AIM: PYC), a company specializing in mathematical modeling and data science for drug development and personalized medicine, has announced its intention to raise up to £70,000 through a retail offer. The offer, made via the Winterflood Retail Access Platform (WRAP), involves issuing up to 14 million new ordinary shares at a price of £0.005 each.

This retail offer is exclusively available to existing shareholders in the United Kingdom (TADAWUL:4280) and complements a separate placing of new ordinary shares aimed at raising approximately £500,000 before expenses. The placing shares, along with the retail offer shares, are collectively referred to as the New Ordinary Shares and are being offered at the same price as the retail offer shares.

The placing price of £0.005 per share represents a 37.5% discount to the mid-market closing price of an ordinary share as of February 12, 2025. The proceeds from both the retail offer and the placing are intended to be used in the same manner, although specific details on the use of proceeds were not disclosed in the press release.

The retail offer is open to eligible investors who are existing shareholders of Physiomics plc as of today or will become shareholders before placing an order for the retail offer shares. The offer is expected to close at 11:00 a.m. on February 17, 2025, but potential participants are advised to be aware of earlier closing times set by financial intermediaries.

Admission of the New Ordinary Shares to trading on AIM is conditional upon the completion of the placing. Trading is anticipated to commence on or around 8:00 a.m. on February 18, 2025.

Physiomics emphasizes the importance of its retail shareholder base and the opportunity this offer provides for their participation. Minimum subscription per investor is set at £100, and terms and conditions, including commission or fee charges, will be provided by the relevant financial intermediaries. The company reserves the right to amend the size of the retail offer and to scale back or reject any application without explanation.

Investors are reminded that once an application for retail offer shares has been made and accepted, it cannot be withdrawn. The New Ordinary Shares, once issued, will rank equally in all respects with the existing ordinary shares.

The offer is being conducted under the exemption from the requirement to publish a prospectus, according to section 86(1)(e) of the Financial Services and Markets Act 2000 (FSMA). This announcement is based on a press release statement and is intended for informational purposes only. It does not constitute an offer, invitation, or solicitation to buy or subscribe for securities of Physiomics PLC.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.